Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill Barber

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
The AAPS Journal|February 10, 2015
Choice of LC-MS methods for the absolute quantification of drug-metabolizing enzymes and transporters in human tissue: a comparative cost analysisHajar Al Feteisi, Brahim Achour, Jill Barber, et al.
Journal of Medicinal Chemistry|March 23, 2013
Effects of gentamicin on the proteomes of aerobic and oxygen-limited Escherichia coliZubida M Al-Majdoub, Abiola Owoseni, Simon J Gaskell, et al.
Annual Review of Analytical Chemistry (Palo Alto, Calif.)|February 22, 2020
Mass Spectrometry of Human TransportersBrahim Achour, Zubida M Al-Majdoub, Amin Rostami-Hodjegan, et al.
Clinical Pharmacokinetics|September 2, 2022
Altered Bioavailability and Pharmacokinetics in Crohn's Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered DrugsSarah Alrubia, Jialin Mao, Yuan Chen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 31, 2022
Examining Physiologically Based Pharmacokinetic Model Assumptions for Cross-Tissue Similarity of Activity per Unit of Enzyme: The Case Example of Uridine 5'-Diphosphate GlucuronosyltransferaseAnika N Ahmed, Amin Rostami-Hodjegan, Jill Barber, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 5, 2017
Global Proteomic Analysis of Human Liver Microsomes: Rapid Characterization and Quantification of Hepatic Drug-Metabolizing EnzymesBrahim Achour, Hajar Al Feteisi, Francesco Lanucara, et al.
Journal of Proteome Research|February 6, 2014
Quantification of the proteins of the bacterial ribosome using QconCAT technologyZubida M Al-Majdoub, Kathleen M Carroll, Simon J Gaskell, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 5, 2025
Pharmacotherapy in kidney disease: what it takes to move from general guidance to specific recommendations to stratified subgroups of patients - the tale of autosomal dominant polycystic kidney disease (ADPKD)Annika C Tillmann, Amin Rostami-Hodjegan, Jill Barber, et al.
International Journal of Antimicrobial Agents|July 3, 2017
16-membered macrolide antibiotics: a reviewBiljana Arsic, Jill Barber, Ana Čikoš, et al.
Proteomics|October 30, 2018
GASP and FASP are Complementary for LC-MS/MS Proteomic Analysis of Drug-Metabolizing Enzymes and Transporters in Pig LiverMartyn Howard, Brahim Achour, Zubida Al-Majdoub, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
The AAPS Journal|February 10, 2015
Choice of LC-MS methods for the absolute quantification of drug-metabolizing enzymes and transporters in human tissue: a comparative cost analysisHajar Al Feteisi, Brahim Achour, Jill Barber, et al.
Journal of Medicinal Chemistry|March 23, 2013
Effects of gentamicin on the proteomes of aerobic and oxygen-limited Escherichia coliZubida M Al-Majdoub, Abiola Owoseni, Simon J Gaskell, et al.
Annual Review of Analytical Chemistry (Palo Alto, Calif.)|February 22, 2020
Mass Spectrometry of Human TransportersBrahim Achour, Zubida M Al-Majdoub, Amin Rostami-Hodjegan, et al.
Clinical Pharmacokinetics|September 2, 2022
Altered Bioavailability and Pharmacokinetics in Crohn's Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered DrugsSarah Alrubia, Jialin Mao, Yuan Chen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 31, 2022
Examining Physiologically Based Pharmacokinetic Model Assumptions for Cross-Tissue Similarity of Activity per Unit of Enzyme: The Case Example of Uridine 5'-Diphosphate GlucuronosyltransferaseAnika N Ahmed, Amin Rostami-Hodjegan, Jill Barber, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 5, 2017
Global Proteomic Analysis of Human Liver Microsomes: Rapid Characterization and Quantification of Hepatic Drug-Metabolizing EnzymesBrahim Achour, Hajar Al Feteisi, Francesco Lanucara, et al.
Journal of Proteome Research|February 6, 2014
Quantification of the proteins of the bacterial ribosome using QconCAT technologyZubida M Al-Majdoub, Kathleen M Carroll, Simon J Gaskell, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 5, 2025
Pharmacotherapy in kidney disease: what it takes to move from general guidance to specific recommendations to stratified subgroups of patients - the tale of autosomal dominant polycystic kidney disease (ADPKD)Annika C Tillmann, Amin Rostami-Hodjegan, Jill Barber, et al.
International Journal of Antimicrobial Agents|July 3, 2017
16-membered macrolide antibiotics: a reviewBiljana Arsic, Jill Barber, Ana Čikoš, et al.
Proteomics|October 30, 2018
GASP and FASP are Complementary for LC-MS/MS Proteomic Analysis of Drug-Metabolizing Enzymes and Transporters in Pig LiverMartyn Howard, Brahim Achour, Zubida Al-Majdoub, et al.
Pageof 8